| Field | Specification |
|---|---|
| Mfr No | |
| Activity | |
| Alternative Names | 3-[2-[4-(4-Fluorobenzoyl)-1-piperidinyl]ethyl]-2,4(1H,3H)-quinazolinedione, tartrate; R41468 |
| Cas No. | |
| Form | White powder |
| Molecular Weight | |
| Product Type | |
| Purity | |
| Shipping | |
| SMILES | |
| Solubility | May be dissolved in DMSO (30 mg/ml); or Water (5 mg/ml) |
| Source | Synthetic |
| Storage |
Ketanserin tartrate is a selective antagonist of the serotonin 5-HT2A receptor, with additional affinity for the 5-HT1Dα receptor. While primarily studied for its cardiovascular effects, including treatment of hypertension post-coronary artery surgery, Ketanserin has gained attention in neuroscience for its ability to modulate serotonergic signaling. It has been used to investigate the cognitive and perceptual effects of 5-HT2A receptor activation, including disruption of hallucinogenic responses. Its role in modulating serotonin pathways makes it a valuable tool in neuropsychiatric and neuropharmacological research.
Classification: Danger.
Hazard Statements:
H301
Precautionary Statements:
P264 - P270 - P301 + P310 - P405 - P501
Ketanserin tartrate (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-618)
Need this compound in a format that drops straight into your assay? We can tailor formulation, chemistry, and documentation so your results stay consistent across runs and re-orders.
- Format options: solid or pre-dissolved solution (choose solvent), target concentration, aliquots, light/moisture-protected packaging
- Chemistry options: free base/acid vs salt forms, hydrate/solvate preference, stereoisomer control (single enantiomer or racemate), close analogs
- Add-on labels & handles: D/¹³C/¹⁵N isotopes (LC-MS/internal standards), azide/alkyne or other functional handles for conjugation
- QC & documentation: standard COA or enhanced analytical pack (HPLC/LC-MS/NMR), chiral purity, residual solvents, water content (KF), method-specific specs
- Scale & continuity: mg to gram scale, bulk pricing, lot reservation, repeat-order continuity
To quote quickly, tell us: compound name + CAS/structure (SMILES or mol file), intended assay context, solvent preference, salt/stereochemistry requirements, purity/QC level, and the amount (mg–g).
Can’t find the compound you’re looking for?
Send the CAS or structure and your specs. We can help source it, suggest close
equivalents, or discuss custom synthesis with the right QC documentation (RUO).
2. Zgombick JM., et al. (1995) Eur. J. Pharmacol. 291:9.
3. Vandenbroucke G., et al.(1994) J. Cardiothorac. Vasc. Anesth. 8: P324.
4. Quednow BB.,et al. (2012) Neuropsychopharmacology. 37:630.
